NoPrescriptionDrugstore.com Order Status FAQ Online Drugstore Affiliate Program Contact NoPrescriptionDrugstore.com No Prescription Drugs Newsletter Refer a Friend
 
Thursday, January 21, 2010  
Steris System 1 Processor: FDA Notice and Recommendations
Steris System 1 Processor: FDA Notice and Recommendations
[UPDATED 12/17/2009] List of alternative products added. Unapproved device with potential for improper sterilization and disinfection.
Source: www.fda.gov

Guideline: Widely Used Device For Pain Therapy Not Recommended For Chronic Low Back Pain
A new guideline issued by the American Academy of Neurology finds that transcutaneous electric nerve stimulation (TENS), a widely used pain therapy involving a portable device, is not recommended to treat chronic low-back pain pain that has persisted for three months or longer because research shows it is not effective...
Source: mnt.to

Intensive, Progressive Physical Therapist Exercise Program Plus Educationreduces Disability And Improves Patient Function After Back Surgery
Patients who have undergone a single-level lumbar microdiskectomy for lumbar disk herniation experienced significant improvement in physical function following an intensive, progressive physical therapist guided exercise and education program, according to a research report published in the November issue of Physical Therapy (PTJ), the scientific journal of the American Physica...
Source: mnt.to

Minimally Invasive Surgery Corrects Scoliosis And Relieves Retired Teacher's Chronic Pain
Carole Riggs, a retired teacher and school principal, points to her work during one Christmas vacation bending, twisting and sitting on the floor to create games and teaching aids as the primary culprit behind many years of back pain. Burak M. Ozgur, M.D...
Source: mnt.to

Aetna Launches New Team-Based Fitness And Nutrition Program To Help People Achieve Healthy Lifestyles
Aetna (NYSE:AET) today announced a new team-based fitness and nutrition program for employers nationwide that uses online social networking to encourage people of all health and fitness levels to work together with their colleagues to achieve their optimal health. Powered by Shape Up The Nation, Aetna Health Connections Get Active!SM is modeled after Aetna's own Get Active Aetna employee program. The program has been exceptionally successful among Aetna's own employees, with 57 percent of employees participating in the program in 2009...



Source: feedproxy.google.com

Survival Of The Fittest Or Survival Of The Cutest
Domestic dogs have followed their own evolutionary path, twisting Darwin's directive 'survival of the fittest' to their own needs - and have proved him right in the process, according to a new study by biologists Chris Klingenberg, of The University of Manchester and Abby Drake, of the College of the Holy Cross in the US. The study, published in The American Naturalist today (20 January 2010), compared the skull shapes of domestic dogs with those of different species across the order Carnivora, to which dogs belong along with cats, bears, weasels, civets and even seals and walruses...



Source: feedproxy.google.com

WIREs Cognitive Science Explores The Rise Of Neurolaw
What if a jury could decide a man's guilt through mind reading? What if reading a defendant's memory could betray their guilt? And what constitutes 'intent' to commit murder? These are just some of the issues debated and reviewed in the inaugural issue of WIREs Cognitive Science, the latest interdisciplinary project from Wiley-Blackwell, which for registered institutions will be free for the first two years...



Source: feedproxy.google.com

Agennix Expands Talactoferrin Phase 3 FORTIS-M Registration Trial Globally
Agennix AG (FRANKFURT: AGX) announced that the next stage of the FORTIS-M trial has begun, with the first patient being dosed in Europe. FORTIS-M is a Phase 3 registration trial evaluating oral talactoferrin versus placebo in advanced non-small cell lung cancer (NSCLC) in patients whose disease has progressed following two or more prior therapies. The trial is expected to enroll approximately 720 patients. Enrollment is ongoing at sites in the U.S. and is now being expanded into Europe and the rest of the world. "Expansion of the FORTIS-M trial to sites outside the U.S...



Source: feedproxy.google.com

Subscribe to Posts [Atom]

Home | Order Status | FAQ | Affiliates | Contact us | Newsletter | Refer a Friend

© 2004 Online Pharmacy. All Rights Reserved.